22 min listen
STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ratings:
Length:
24 minutes
Released:
Apr 20, 2024
Format:
Podcast episode
Description
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, tackle a pair of related topics: what the STEP HFpEF DM trial from ACC.24 means for the diabetes community and the need for fair and equitable allocation of incretin-based therapies in the face of ongoing drug shortages and overwhelming demand.
Released:
Apr 20, 2024
Format:
Podcast episode
Titles in the series (94)
Diabetes Research & COVID-19 by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives